Robert Bies

  • 2434 Citations
  • 27 h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robert Bies is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Pharmacokinetics Medicine & Life Sciences
olanzapine Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Population Medicine & Life Sciences
Risperidone Medicine & Life Sciences
Dopamine D2 Receptors Medicine & Life Sciences
Citalopram Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 2011 2016

Indiana University Center for Pediatric Pharmacology

Flockhart, D. A., Renbarger, J., Bies, R., Renbarger, J., Robertson, K., Bies, R. R., Haneline, L., Flockhart, D. A., Haneline, L., Robertson, K. & Bies, R.

National Institutes of Health

9/26/116/30/16

Project: Research project

Biomarkers
Pharmacology
Pediatrics
Genomics
Proteomics

Publications 2001 2019

Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology

Koizumi, T., Suzuki, T., Pillai, N. S., Bies, R., Takeuchi, H., Yoshimura, K., Mimura, M. & Uchida, H., Oct 1 2019, In : Journal of Psychiatric Research. 117, p. 1-6 6 p.

Research output: Contribution to journalArticle

Hallucinations
Schizophrenia
Pharmacology
Dopamine D2 Receptors
olanzapine

Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP), Jan 1 2019, In : Pharmaceutical Statistics.

Research output: Contribution to journalLetter

Pharmaceuticals
Curriculum
Drugs
Statistics
Pharmaceutical Preparations

Estimating parameters of nonlinear dynamic systems in pharmacology using chaos synchronization and grid search

Pillai, N., Schwartz, S. L., Ho, T., Dokoumetzidis, A., Bies, R. & Freedman, I., Jan 1 2019, In : Journal of Pharmacokinetics and Pharmacodynamics.

Research output: Contribution to journalArticle

Open Access
Nonlinear Dynamics
Hydrocortisone
Pharmacology
Least-Squares Analysis
Research

Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach

Kay, K., Dolcy, K., Bies, R. & Shah, D. K., Mar 1 2019, In : AAPS Journal. 21, 2, 27.

Research output: Contribution to journalArticle

Disease-Free Survival
Neoplasms
Growth
Hepatocellular Carcinoma
Stomach Neoplasms

Model-guided antipsychotic dose reduction in schizophrenia: A pilot, single-blind randomized controlled trial

Ozawa, C., Bies, R., Pillai, N., Suzuki, T., Mimura, M. & Uchida, H., Jul 1 2019, In : Journal of Clinical Psychopharmacology. 39, 4, p. 329-335 7 p.

Research output: Contribution to journalArticle

Antipsychotic Agents
Schizophrenia
olanzapine
Randomized Controlled Trials
Maintenance